Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

NCT06177691 · clinicaltrials.gov ↗
UNKNOWN
Status
77
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Jaeb Center for Health Research

Collaborators